drugset / Trial / NCT02443402
Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to compare sitagliptin and placebo for the prevention of high blood glucose during surgery.
Timeline
- Start
- 2016-01
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sitagliptin | Small molecule | 25 mg | Oral |
| Subject | Sitagliptin | Small molecule | 50 mg | Oral |
| Subject | Sitagliptin | Small molecule | 100 mg | Oral |
| Background | Insulin | Protein / enzyme biologic | — | Intravenous |
| Background | Insulin Lispro | Protein / enzyme biologic | — | — |
| Background | insulin aspart | Protein / enzyme biologic | — | — |
| Background | insulin glargine | Protein / enzyme biologic | — | — |